CytoNiche Launches 3D FloTrix Experience Center in Singapore to Advance Affordable Stem Cell Therapies
Singapore, July 22, 2025 – CytoNiche Biotech, a leader in 3D cell mass production technology, has opened its 3D FloTrix Experience Center in Singapore. This milestone marks a key step in the company’s global expansion, showcasing the technology behind China’s first approved stem cell therapy, with costs estimated by the company to be a fraction of comparable Western therapies. The high cost of stem cell therapies remains a global barrier. For example, stem cell therapy costs $1.55 million per treatment
Read more